As­traZeneca culls its neu­ro­science team, ex­its Kendall Square of­fice

It turns out that As­traZeneca has been us­ing its prun­ing shears on staff in Cam­bridge, MA as well as down in Gaithers­burg, MD, where we re­port­ed last week that the com­pa­ny has been culling the ranks at Med­Im­mune as part of a com­pa­ny-wide ef­fort to shift more re­sources in­to on­col­o­gy.

In this case, it’s the neu­ro­science team that is feel­ing the ef­fects of the com­pa­ny’s ef­forts to “ap­pro­pri­ate­ly size” its glob­al R&D force.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER